Finance entity
CRA International is the most frequent co-covered peer, appearing in 1 of the 2 tracked stories. That works out to roughly 0.6 stories per week across a 25-day span. At 5, the average consequence score sits below the same-window beat average of 6.3.
Last mentioned: Mar 21, 2026
Entity pulse
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
CRA International is the most frequent co-covered peer, appearing in 1 of the 2 tracked stories. That works out to roughly 0.6 stories per week across a 25-day span. At 5, the average consequence score sits below the same-window beat average of 6.3. They are better corroborated than the beat average, carrying 3.5 original sources each against 2.6 for the same window. The clearest coverage concentration is earnings: 1 of 2 stories, with the rest divided among 1 other category. Viatris appears in 2 tracked Finance stories published from February 25, 2026 through March 21, 2026.
Computed from the 2 stories linked to this entity, with beat comparisons drawn from all 2074 Finance stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering Viatris. Shared-story counts are live from our verified record — not editorial picks.
Invenomic Capital Management has fully liquidated its $24.3 million stake in Haemonetics Corporation (HAE) following a period of significant market underperformance. The move signals a strategic shift for the fund as it reallocates capital toward more resilient healthcare and technology holdings.
A diverse group of mid-to-large cap companies across consumer staples, healthcare, and tech are set to report Q4 results tomorrow. Investors are looking for signs of margin expansion amid stabilizing inflation and the impact of generative AI on software demand.
Viatris is linked from 2 stories on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.
